GASTROINTESTINAL STROMAL CANCER

Clinical trials for GASTROINTESTINAL STROMAL CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTROINTESTINAL STROMAL CANCER trials appear

Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough stomach tumors: experimental drug combo enters human testing

Disease control Recruiting now

This early-stage trial is testing the safety and initial effectiveness of a new oral drug, ziftomenib, when given alongside the standard drug imatinib. It is for adults with advanced gastrointestinal stromal tumors (GIST) whose cancer has continued to grow despite treatment with …

Matched conditions: GASTROINTESTINAL STROMAL CANCER

Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

GASTROINTESTINAL STROMAL CANCER

Get alerted when new GASTROINTESTINAL STROMAL CANCER trials appear

New hope for tough stomach tumors: experimental drug combo enters human testing